Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,070
Closed -$213K 46
2026
Q1
$213K Sell
1,070
-900
-46% -$205K 0.07% 52
2025
Q4
$428K Hold
1,970
0.14% 39
2025
Q3
$425K Sell
1,970
-2,400
-55% -$541K 0.13% 44
2025
Q2
$916K Buy
4,370
+400
+10% +$75.6K 0.31% 35
2025
Q1
$677K Hold
3,970
0.26% 36
2024
Q4
$703K Buy
3,970
+300
+8% +$47.1K 0.24% 42
2024
Q3
$558K Hold
3,670
0.2% 44
2024
Q2
$668K Hold
3,670
0.25% 49
2024
Q1
$708K Hold
3,670
0.26% 47
2023
Q4
$957K Hold
3,670
0.37% 47
2023
Q3
$703K Buy
+3,670
New +$803K 0.31% 49

Other funds holding BA

Altrafin AG's BA Position: Q2 2026 in Review

Altrafin AG sold out of Boeing (BA) in Q2 2026, closing a stake of 1,070 shares — an estimated $213K sold.

Altrafin AG first reported a position in BA in Q3 2023 and held it in 11 quarters. The position peaked at $957K in Q4 2023. 2,617 funds tracked by Wall St. Rank hold BA as of Q2 2026.

  • Altrafin AG reported no remaining Boeing position as of Q2 2026 after selling out during the quarter.
  • Altrafin AG sold 1,070 Boeing shares in Q2 2026, an estimated $213K.
  • Altrafin AG first reported a position in Boeing in Q3 2023 and held it in 11 quarters.
  • Altrafin AG's Boeing position peaked at $957K in Q4 2023.
  • 2,617 funds tracked by Wall St. Rank held Boeing as of Q2 2026.

Based on Altrafin AG's 13F filing for Q2 2026, filed 15 Jul 2026.